Author: Richard Partington

Mitochondria are no longer viewed solely as the cell’s “powerhouses.” They are now recognized as central regulators of human health, disease, and aging, influencing everything from energy production and metabolism to immune function and cell fate. Advances in mitochondrial research are driving new frontiers in precision medicine, offering novel approaches for diagnosing, preventing, and treating a broad range of conditions, including neurodegenerative disorders, metabolic syndromes, cardiovascular disease, cancer, and age-related decline.Read More

Read More

Katy Kaminski, chief research strategist and portfolio manager at Alphasimplex Group, discusses market moves and investor sentiment. Speaking on Bloomberg Television, she say bets on further Federal Reserve interest rate cuts, as well as investors looking at diversifying, could mean there “might be an opportunity for small caps going forward.” She also talks about big tech names, saying “investor sentiment continues to be strong.” (Source: Bloomberg)Read More

Read More

As global markets experience shifts, with the Nasdaq Composite reaching new highs and China’s exports showing resilience despite trade tensions, the Asian tech sector continues to capture investor interest. In this dynamic environment, identifying high-growth tech stocks involves evaluating companies that demonstrate strong innovation and adaptability to evolving market conditions.Read More

Read More